Ruti Aga's Six-Year Ban: Two Years for the Drug, Four for the Forged Slip

The heaviest sentence in the Athletics Integrity Unit's statement on Thursday is not written in medical vocabulary; it is written in bookkeeping. The “doctor” who signed the prescription was a family member of Ruti Aga with no medical registration to his name. He said he used “an old prescription pad from a former workplace.” The clinic printed on the slip said, plainly, that it had no connection to the document. Three independent verifications, three failures at the same point.

The decisive evidence became the slip filed during the investigation. Aga, 32, is serving six years from 10 September: two years for the presence of a prohibited substance, four for tampering with the investigation. The half marathon she won in China in March, its prize money, and the ranking points accrued after it are all in question. The AIU statement does not spell out the scope of disqualification, though its standard practice voids the result of the competition at which the sample was collected.

Her record needs no introduction. The 2026 Tokyo Marathon title is hers, along with three second-place finishes at World Marathon Majors. Berlin 2026, second in 2:18:34 — that figure comes from the public results archive, not from the AIU statement, so I am logging it in a separate column. The March half marathon's time, its splits, the depth of its field: none of it appears in the source. The one fact available is that she won it, which implies a World Athletics Label-tier elite field with in-competition testing present.

The depth of Ethiopian women's marathoning decides the weight of this ban. The country's top end has already reached sub-2:12, and a 2:18–2:20 performer is not automatically selectable. One athlete's removal does not shift a national team's medal arithmetic by any measurable margin. That is a bitter sentence, but it is what the record says. The habit I built after the 2026 Asian Championships in Bhubaneswar still holds: one meet's number is not a trend, and one title is not a career.

The sanction arithmetic is plain: two plus four, six. Two years for an S9 substance matches the situation where intent is not proven; four years is the standard tampering sanction. The sum also tells us the panel rejected the no-significant-fault route, which would otherwise have reduced the presence sanction. Backdating to 10 September is a procedural benefit, not a discount; provisional suspension time counts against the ban. A doping panel's verdict is a paper trail with consequences, not a ceremony, and here the paper collected the heaviest price.

A technical correction is necessary, because early reports called methylprednisolone a “prohibited steroid” and said WADA classes it as performance enhancing. That is imprecise. It is a glucocorticoid, WADA Prohibited List class S9, not an anabolic steroid (S1). Under the current List, S9 substances are prohibited in-competition only, and only by injection, oral or rectal route. A therapeutic knee injection out of competition is entirely legal. A road race's testing window opens at 23:59 the day before the race, so an injection given days earlier is caught. The outcome was decided by route and timing relative to competition; the “steroid” vocabulary blurred exactly that point.

The defence existed, and that is the hardest truth in this case. Genuine medical records could have supported a no-fault argument; a TUE and correct washout timing would have produced no case at all. Knee synovitis is physiologically plausible in distance runners — chronic knee pathology is a known load-bearing failure in high-volume marathoners — and that plausibility is precisely what makes the forgery decisive. Real treatment gets defended with real records.

Three verification failures sit on the file together: the clinic did not exist, the signatory was unregistered, and the clinic disowned the “old pad” claim. A family member serving as the doctor aggravates rather than mitigates. This is not a filing error; it is the signature of an athlete operating without a credentialed team physician. No TUE infrastructure appears anywhere. After the knee hurt, two roads were open — documents, or concealment. The second was taken.

The headline will read “steroid cheat,” and the data do not support it. Glucocorticoids have no proven endurance benefit. A six-year ban for a substance with no established performance gain will be quoted from both directions: as proof of AIU rigour, and as proof of disproportionate enforcement against African road runners. I would lower the temperature. The four years are for the paperwork, and the tampering finding is document-based and hard to overturn at CAS. Do not lose the fact in the sympathy.

What the file does not contain is also a finding. No mark, no split, no field strength, no stated scope of disqualification, and no statement from the Ethiopian federation. Only the AIU has spoken. Before I call it culture, I want to see who kept the receipts. The lesson I noted at the Gold Coast relay selection dispute in 2026 applies here: a review is a paper trail with consequences, and what is absent from it counts as well.

The larger signal is at field level, where the AIU's road-racing tampering cases are clustering. The enforcement frontier is sliding from detection to document verification. China's label-race circuit — large appearance-fee budgets, deep East African elite fields, AIU testing — has become a high-scrutiny zone. Where a race's money and its testing share the same track, integrity risk now travels with the result.

The next variable is in the dates. The CAS appeal window runs about 21 days, and the tampering finding rests on documents. Second: when the March result and its prize money are formally voided — the source is silent, the ledger will not be. Third: whether the agent or management is investigated, because for now the file names only a family member. The raw sheet had two stories; I followed the one with a receipt. And the next time a 2:18 marathoner vanishes from a start list, the first question will be whose name was on the prescription.